Evidences show that inhibition of TGF-β signaling by neutralizing TGF-β1 antibodies or soluble TGF-β receptor ameliorates renal fibrosis in vivo and in vitro [10–13, 25]. This evidence concerns the gene TGFB1 and renal fibrosis.